PATENT CLAIM ANALYSIS

Application Number: 15881231
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["514", "183000"]

Abstract:
The present invention discloses novel agents and methods for diagnosis and treatment of melanoma. Also disclosed are related arrays, kits, and screening methods.

Claim (Index 69):
An array comprising\n a support having a plurality of unique locations, and any combination of (i) at least one nucleic acid having a sequence that is complementary to a nucleic acid encoding a metastasis promoter factor selected from the group consisting of miR-199a-3p, miR-199a-5p, miR-1908, and CTGF or a complement thereof, or (ii) at least one nucleic acid having a sequence that is complementary to a nucleic acid encoding a metastasis suppressor factor selected from the group consisting of DNAJA4, ApoE, LRP1, LRP8, Liver X Receptor (LXR), and miR-7 or a complement thereof, wherein each nucleic acid is immobilized to a unique location of the support.

Metadata:
- Claim Count in Document: 143.0
- Percentile: 86.0
- Lexical Diversity: 1.22727
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15228643', '14486477', '15650480', '14486466', '14678628']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8721718333418101
- 35 USC 102 Novelty (BERT): 0.6219345283683753
- Combined Prediction Score: 0.8471481028444666
- Mean Citation Score: 749.8811079999997
- Max Citation Score: 894.0029
- Similarity Product: 510.67354489336014

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test